Skip to content

ENDO-AID Assisted Tandem Colonoscopy RCT

Assessment of Efficacy of ENDO-AID Assisted Colonoscopy in Adenoma Detection: a Single Centre Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05013125
Enrollment
360
Registered
2021-08-19
Start date
2021-08-18
Completion date
2023-04-30
Last updated
2024-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasms

Keywords

Computer aided Polyp detection, Colonoscopy, Polyp detection, Colorectal polyps, Colorectal cancer

Brief summary

This study hypothesizes that more adenomas will be detected using the ENDO-AID assisted Colonoscopy compared to conventional colonoscopy. A single-centre, randomized, same-day, back-to-back tandem colonoscopy trial comparing Adenoma Missed Rate and Adenoma Detection Rate in ENDO-AID assisted colonoscopy and conventional colonoscopy.

Detailed description

Colorectal cancer is the third common cancer in the world and the commonest cancer in Hong Kong. Most sporadic colorectal cancers arise from benign polyps via adenoma-carcinoma sequence or the serrated polyp-carcinoma sequence. There are reports of unexpectedly high risk of interval carcinomas, as high as up to 9%, raising concerns about the effectiveness of colonoscopy in preventing colorectal cancers. Different techniques have been described to improve the area of mucosa visualised but lesions may still be missed due to failure of identification by the endoscopist. Computer Aided diagnosis (CAD) assisted colonoscopy is becoming increasingly popular to address human error. Deep learning technology has surpassed human learning and advancement in technology now allows real-time Artificial Intelligence to assist colonoscopists in polyp detection.

Interventions

DIAGNOSTIC_TESTENDO-AID CADe assisted Colonoscopy

ENDO-AID is a dedicated endoscopy Computer-Aided Diagnosis (CADe) system where suspicious lesions are automatically detected and highlighted on the main monitor in real-time, alerting the endoscopist during the procedure.

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 18years or above * Referred to endoscopy unit for diagnostic or surveillance colonoscopy

Exclusion criteria

* Familial history of Familial adenomatous polyposis / Hereditary non-polyposis colorectal cancer * Known history of inflammatory bowel disease * Known colitis or suspicion of colitis (inflammatory bowel disease, diverticulitis, infective colitis) * Emergency endoscopy of any nature (eg gastrointestinal bleeding, colonic decompression) * Previous incomplete colonoscopy (not including insufficient preparation) / difficult colonoscopy * Patients referred for a therapeutic procedure or assessment of a known non-resected lesion * Patients with known palliative colorectal malignancy * Patient with coagulopathy * Patient with colostomy * Patient with multiple co-morbidities (American Society of Anaesthesiologist \>3) * Inability to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Adenoma missed rateEnd of study, about 1 yearTo compare the adenoma missed rate (AMR) between ENDO-AID assisted Colonoscopy and conventional colonoscopy. AMR is defined as the number of adenomas detected in the second pass colonoscopy divided by the total number of adenomas detected in both passes for the same patients.

Secondary

MeasureTime frameDescription
Adenoma detection rateEnd of study, about 1 yearTo compare the Adenoma detection rate (ADR) between ENDO-AID assisted Colonoscopy and conventional colonoscopy for the first pass colonoscopy. ADR is defined as the proportion of patients with at least 1 adenoma detected in the first pass colonoscopy.
Patient missed rateEnd of study, about 1 yearTo compare the patient missed rate (PMR) between ENDO-AID assisted colonoscopy and conventional white light colonoscopy. PMR is defined as the number of patients in whom adenomas were detected for the first time during second pass colonoscopy divided by the number of patients with at least 1 adenoma detected.
Number of polyps removedEnd of study, about 1 yearTo compare the number of polyps removed between ENDO-AID assisted Colonoscopy and conventional white light colonoscopy
Polyp missed rateEnd of study, about 1 yearTo compare the Polyp missed rate (PMR) between ENDO-AID assisted Colonoscopy and conventional colonoscopy. PMR is defined as the number of polyps detected in the second pass colonoscopy divided by the total number of polyps detected in both passes for the same patients.
Serious Adverse EventsAt 30 daysTo compare the Serious Adverse Events between ENDO-AID assisted Colonoscopy and conventional white light colonoscopy
Number of CAD assisted abnormalityEnd of study, about 1 yearNumber of abnormalities highlighted on ENDO-AID and actual number of abnormalities found macroscopically and histologically
Baseline ParametersEnd of study, about 1 yearBaseline Parameters will be compared, including withdrawal time and Boston Bowel Preparation Scale in the first colonoscopy procedures

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026